McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
869.58
-1.80 (-0.21%)
Aug 7, 2026, 4:00 PM EDT - Market closed
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 340.70B | 343.88B | 347.92B | 346.71B | 345.96B | 327.72B | 313.34B | 299.25B | |||||||||||||||||
| U.S. Pharmaceutical Growth | -1.52% | 4.93% | 11.04% | 15.86% | 22.12% | 17.57% | 15.36% | 14.86% | |||||||||||||||||
| Oncology & Multispecialty | 51.99B | 37.77B | 25.05B | 12.04B | - | - | - | - | |||||||||||||||||
| Prescription Technology Solutions | 5.94B | 5.81B | 5.65B | 5.52B | 5.41B | 5.22B | 5.06B | 4.89B | |||||||||||||||||
| Prescription Technology Solutions Growth | 9.76% | 11.29% | 11.71% | 12.86% | 13.49% | 9.37% | 5.99% | 4.35% | |||||||||||||||||
| Medical-Surgical Solutions | - | - | 11.49B | 11.45B | 11.45B | 11.39B | 11.37B | 11.45B | |||||||||||||||||
| Medical-Surgical Solutions Growth | - | - | 1.07% | -0.02% | 1.00% | 0.65% | 1.84% | 2.99% | |||||||||||||||||
| Other | 738.00M | 738.00M | 637.00M | 302.00M | - | - | - | - | |||||||||||||||||
| International | - | 3.74B | 7.20B | 11.06B | 14.77B | 14.72B | 14.81B | 14.59B | |||||||||||||||||
| International Growth | - | -74.61% | -51.38% | -24.19% | 2.89% | 4.18% | 6.19% | -1.14% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 3.97B | 3.79B | 3.93B | 3.73B | 3.95B | 4.00B | 3.77B | 3.22B | |||||||||||||||||
| U.S. Pharmaceutical Growth | 0.48% | -5.27% | 4.17% | 15.61% | 44.09% | 43.65% | 51.30% | 6.20% | |||||||||||||||||
| Oncology & Multispecialty | 1.26B | 937.00M | 636.00M | 332.00M | - | - | - | - | |||||||||||||||||
| Prescription Technology Solutions | 1.02B | 1.04B | 1.01B | 964.00M | 925.00M | 875.00M | 815.00M | 774.00M | |||||||||||||||||
| Prescription Technology Solutions Growth | 9.95% | 19.31% | 23.44% | 24.55% | 14.62% | 4.79% | 0.25% | 0.39% | |||||||||||||||||
| Medical-Surgical Solutions | 839.00M | 938.00M | 933.00M | 937.00M | 806.00M | 773.00M | 759.00M | 758.00M | |||||||||||||||||
| Medical-Surgical Solutions Growth | 4.09% | 21.35% | 22.92% | 23.61% | -11.72% | -18.80% | -21.99% | -26.62% | |||||||||||||||||
| Other | 577.00M | 577.00M | 59.00M | 28.00M | - | - | - | - | |||||||||||||||||
| International | - | 92.00M | 186.00M | 297.00M | -211.00M | -213.00M | -237.00M | -222.00M |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, Distribution, General, and Administrative | 8.16B | 8.10B | 8.28B | 8.27B | 8.70B | 8.51B | 8.72B | 9.20B | |||||||||||||||||
| Selling, Distribution, General, and Administrative Growth | -6.18% | -4.83% | -5.11% | -10.07% | -0.98% | -1.73% | 3.43% | 17.50% | |||||||||||||||||
| Restructuring, Impairment, and Other | 334.00M | 245.00M | 73.00M | 69.00M | 177.00M | 140.00M | 244.00M | 216.00M | |||||||||||||||||
| Restructuring, Impairment, and Other Growth | 88.70% | 75.00% | -70.08% | -68.06% | 142.47% | 21.74% | 16.75% | -8.47% | |||||||||||||||||
| Claims and Litigation | -37.00M | -3.00M | -2.00M | -2.00M | -4.00M | 108.00M | 257.00M | 257.00M | |||||||||||||||||
| Claims and Litigation Growth | - | - | - | - | - | -26.53% | - | - |